132 related articles for article (PubMed ID: 3717716)
1. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
Nathan RA; Bodman SF; Storms WW; Mingo TS
Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
[TBL] [Abstract][Full Text] [Related]
3. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
[TBL] [Abstract][Full Text] [Related]
4. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
[TBL] [Abstract][Full Text] [Related]
5. Terbutaline sulfate and isoproterenol sulfate (metered dose aerosols) in the treatment of asthma.
Kemp JP; Orgel HA; Meltzer EO; Welch MJ
Ann Allergy; 1983 Oct; 51(4):436-40. PubMed ID: 6354007
[TBL] [Abstract][Full Text] [Related]
6. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Orgel HA; Kemp JP; Tinkelman DG; Webb DR
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
[TBL] [Abstract][Full Text] [Related]
8. Bitolterol mesylate in exercise-induced asthma.
Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
[TBL] [Abstract][Full Text] [Related]
9. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring.
Kemp JP; Chervinsky P; Orgel HA; Meltzer EO; Noyes JH; Mingo TS
J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):32-43. PubMed ID: 6693665
[TBL] [Abstract][Full Text] [Related]
10. Procaterol metered-dose inhaler: a multiclinic study evaluating the efficacy and safety in patients with asthma.
Storms WW; Chervinsky P; Bell T; Kemp JP; Brandon ML; Reed CE; Siegel SC; Repsher L
Ann Allergy; 1989 Nov; 63(5):444-8. PubMed ID: 2573298
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma.
Bierman CW; Kemp JP; Nathan RA
Ann Allergy Asthma Immunol; 1996 Jan; 76(1):27-35. PubMed ID: 8564625
[TBL] [Abstract][Full Text] [Related]
12. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
[TBL] [Abstract][Full Text] [Related]
13. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects.
Kass I; Mingo TS
Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of fenoterol aerosol in asthma.
Chervinsky P
Ann Allergy; 1977 Sep; 39(3):179-83. PubMed ID: 900585
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
17. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
19. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
Minatoya H
J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of acute effects of albuterol and isoproterenol sulphate aerosols in bronchial asthma.
Mahajan VK; Tomashefski JF; Huber GL
Ann Allergy; 1977 Nov; 39(5):319-24. PubMed ID: 335924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
